MBX Biosciences, Inc. (MBX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MBX Biosciences, Inc. (MBX:NASDAQ), powered by AI.

Current Price
$35.51
Sector
Healthcare
What is the MBX Biosciences, Inc. stock price forecast?

MBX Biosciences, Inc. is currently trading at $35.51. View real-time AI analysis on Alpha Lenz.

What is MBX Biosciences, Inc. insider trading activity?

View the latest insider trading data for MBX Biosciences, Inc. on Alpha Lenz.

What is MBX Biosciences, Inc.'s P/E ratio?

View MBX Biosciences, Inc.'s valuation metrics on Alpha Lenz.

MBX Biosciences, Inc.

NASDAQ · MBX
$35.51-1.74(-4.67%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about MBX Biosciences, Inc.'s future dividend policy...
Alpha Chat Insight

MBX Biosciences, Inc.'s ROE is -27.8%. Explore profitability and growth together.

Ask for details

Company Overview

Mbx Biosciences Inc. is a biopharmaceutical company focused on the research and development of innovative endocrine therapeutics. It strives to address unmet medical needs through pioneering treatments for endocrine disorders. The company's central aim is to develop precision endocrinology therapies, leveraging proprietary technologies to create treatment options that are more precise and effective for specific patient populations. Mbx Biosciences operates at the intersection of biotechnology and healthcare, significantly impacting the health sector by working towards solutions that can transform the management of hormonal disorders. In terms of market significance, Mbx Biosciences represents the advancing frontier of personalized medicine, emphasizing targeted therapies that promise improved outcomes and quality of life for patients suffering from conditions related to hormonal imbalances. By contributing to the biopharmaceutical landscape with innovative solutions, it holds a vital role in advancing both the scientific understanding and therapeutic interventions in endocrine health.

CEOMr. Peter Kent Hawryluk MBA
SectorHealthcare
IndustryBiotechnology
Employees43

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
43Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-26.61%ROA
-27.76%ROE
-30.00%ROIC

Financial Health

$75.29MCash & Cash Equivalents
$-59.37MNet Debt
4.31%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

MBX Biosciences, Inc. (ticker: MBX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 43 employees.

The current price is $35.51 with a P/E ratio of -x and P/B of -x.

ROE is -27.76%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
MBX Biosciences, Inc. (MBX) Stock Forecast 2026 $35.51 — Price, Financials & Analyst Targets | Alpha Lenz